FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282034009> ?p ?o ?g. }

• W4282034009 endingPage "1396" @default.
• W4282034009 startingPage "1387" @default.
• W4282034009 abstract "Although systemic embolism is a potential complication in transthyretin amyloid cardiomyopathy (ATTR-CM), data about its incidence and prevalence are scarce. We studied the incidence, prevalence and factors associated with embolic events in ATTR-CM. Additionally, we evaluated embolic events according to the type of oral anticoagulation (OAC) and the performance of the CHA2 DS2 -VASc score in this setting.Clinical characteristics, history of atrial fibrillation (AF) and embolic events were retrospectively collected from ATTR-CM patients evaluated at four international amyloid centres. Overall, 1191 ATTR-CM patients (87% men, median age 77.1 years [interquartile range-IQR 71.4-82], 83% ATTRwt) were studied. A total of 162 (13.6%) have had an embolic event before initial evaluation. Over a median follow-up of 19.9 months (IQR 9.9-35.5), 41 additional patients (3.44%) had an embolic event. Incidence rate (per 100 patient-years) was 0 among patients in sinus rhythm with OAC, 1.3 in sinus rhythm without OAC, 1.7 in AF with OAC, and 4.8 in AF without OAC. CHA2 DS2 -VASc did not predict embolic events in patients in sinus rhythm whereas in patients with AF without OAC, only those with a score ≥4 had embolic events. There was no difference in the incidence rate of embolism between patients with AF treated with vitamin K antagonists (VKAs) (n = 322) and those treated with direct oral anticoagulants (DOACs) (n = 239) (p = 0.66).Embolic events were a frequent complication in ATTR-CM. OAC reduced the risk of systemic embolism. Embolic rates did not differ with VKAs and DOACs. The CHA2 DS2 -VASc score did not correlate well with clinical outcome in ATTR-CM and should not be used to assess thromboembolic risk in this population." @default.
• W4282034009 created "2022-06-13" @default.
• W4282034009 creator A5009073324 @default.
• W4282034009 creator A5010380434 @default.
• W4282034009 creator A5011814572 @default.
• W4282034009 creator A5033485687 @default.
• W4282034009 creator A5036001935 @default.
• W4282034009 creator A5043157234 @default.
• W4282034009 creator A5044435830 @default.
• W4282034009 creator A5047800254 @default.
• W4282034009 creator A5049121098 @default.
• W4282034009 creator A5050125018 @default.
• W4282034009 creator A5052065307 @default.
• W4282034009 creator A5057365396 @default.
• W4282034009 creator A5059417970 @default.
• W4282034009 creator A5062816598 @default.
• W4282034009 creator A5064064077 @default.
• W4282034009 creator A5081406713 @default.
• W4282034009 creator A5087457048 @default.
• W4282034009 creator A5088203321 @default.
• W4282034009 date "2022-07-11" @default.
• W4282034009 modified "2023-10-14" @default.
• W4282034009 title "Systemic embolism in amyloid transthyretin cardiomyopathy" @default.
• W4282034009 cites W2025788865 @default.
• W4282034009 cites W2033060908 @default.
• W4282034009 cites W2079055620 @default.
• W4282034009 cites W2117848442 @default.
• W4282034009 cites W2160180604 @default.
• W4282034009 cites W2162586165 @default.
• W4282034009 cites W2254731646 @default.
• W4282034009 cites W2337532627 @default.
• W4282034009 cites W2594063085 @default.
• W4282034009 cites W2624797765 @default.
• W4282034009 cites W2888036721 @default.
• W4282034009 cites W2929109818 @default.
• W4282034009 cites W2970261800 @default.
• W4282034009 cites W2995939088 @default.
• W4282034009 cites W3016412451 @default.
• W4282034009 cites W3016622083 @default.
• W4282034009 cites W3045911085 @default.
• W4282034009 cites W3080859202 @default.
• W4282034009 cites W3088768951 @default.
• W4282034009 cites W3121621820 @default.
• W4282034009 cites W3145296972 @default.
• W4282034009 cites W3158431281 @default.
• W4282034009 cites W3159802509 @default.
• W4282034009 cites W3195462635 @default.
• W4282034009 cites W3216171309 @default.
• W4282034009 doi "https://doi.org/10.1002/ejhf.2566" @default.
• W4282034009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35650018" @default.
• W4282034009 hasPublicationYear "2022" @default.
• W4282034009 type Work @default.
• W4282034009 citedByCount "19" @default.
• W4282034009 countsByYear W42820340092022 @default.
• W4282034009 countsByYear W42820340092023 @default.
• W4282034009 crossrefType "journal-article" @default.
• W4282034009 hasAuthorship W4282034009A5009073324 @default.
• W4282034009 hasAuthorship W4282034009A5010380434 @default.
• W4282034009 hasAuthorship W4282034009A5011814572 @default.
• W4282034009 hasAuthorship W4282034009A5033485687 @default.
• W4282034009 hasAuthorship W4282034009A5036001935 @default.
• W4282034009 hasAuthorship W4282034009A5043157234 @default.
• W4282034009 hasAuthorship W4282034009A5044435830 @default.
• W4282034009 hasAuthorship W4282034009A5047800254 @default.
• W4282034009 hasAuthorship W4282034009A5049121098 @default.
• W4282034009 hasAuthorship W4282034009A5050125018 @default.
• W4282034009 hasAuthorship W4282034009A5052065307 @default.
• W4282034009 hasAuthorship W4282034009A5057365396 @default.
• W4282034009 hasAuthorship W4282034009A5059417970 @default.
• W4282034009 hasAuthorship W4282034009A5062816598 @default.
• W4282034009 hasAuthorship W4282034009A5064064077 @default.
• W4282034009 hasAuthorship W4282034009A5081406713 @default.
• W4282034009 hasAuthorship W4282034009A5087457048 @default.
• W4282034009 hasAuthorship W4282034009A5088203321 @default.
• W4282034009 hasBestOaLocation W42820340091 @default.
• W4282034009 hasConcept C119060515 @default.
• W4282034009 hasConcept C120665830 @default.
• W4282034009 hasConcept C121157162 @default.
• W4282034009 hasConcept C121332964 @default.
• W4282034009 hasConcept C126322002 @default.
• W4282034009 hasConcept C164705383 @default.
• W4282034009 hasConcept C2775914520 @default.
• W4282034009 hasConcept C2777185221 @default.
• W4282034009 hasConcept C2778198053 @default.
• W4282034009 hasConcept C2778797674 @default.
• W4282034009 hasConcept C2779161974 @default.
• W4282034009 hasConcept C61511704 @default.
• W4282034009 hasConcept C71924100 @default.
• W4282034009 hasConcept C81182388 @default.
• W4282034009 hasConceptScore W4282034009C119060515 @default.
• W4282034009 hasConceptScore W4282034009C120665830 @default.
• W4282034009 hasConceptScore W4282034009C121157162 @default.
• W4282034009 hasConceptScore W4282034009C121332964 @default.
• W4282034009 hasConceptScore W4282034009C126322002 @default.
• W4282034009 hasConceptScore W4282034009C164705383 @default.
• W4282034009 hasConceptScore W4282034009C2775914520 @default.
• W4282034009 hasConceptScore W4282034009C2777185221 @default.
• W4282034009 hasConceptScore W4282034009C2778198053 @default.

• next